Literature DB >> 22559107

Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.

Filippo Scarpa1, Silvia Sabattini, Laura Marconato, Ombretta Capitani, Maria Morini, Giuliano Bettini.   

Abstract

OBJECTIVE: To assess the usefulness of histologic evaluation of surgical margins to predict local recurrence of cutaneous malignant tumors in dogs and cats treated by means of surgical excision.
DESIGN: Prospective case series. ANIMALS: 40 dogs and 20 cats. PROCEDURES: 60 surgically excised tumors (20 soft tissue sarcomas [STSs], 20 mast cell tumors [MCTs], and 20 carcinomas) were examined histologically. Margins were classified as clean, close, or infiltrated; histologic grade was assessed in STSs and MCTs. Recurrence rates and recurrence-free intervals (RFIs) during a 24-month follow-up period were recorded, and method accuracy was calculated.
RESULTS: Surgical margins were clean in 29 of 60 (48%) tumors, close in 11 (18%), and infiltrated in 20 (33%). Tumors recurred in 27 of 60 (45%) animals, with a mean ± SD RFI of 229 ± 173 days. Recurrence rates for animals that had tumors with infiltrated (16/20) or close (8/11) margins were significantly higher than recurrence rate for animals that had tumors with clean margins (3/29). Margin classification was a significant predictor of RFI. Accuracy of the method to predict recurrence was 94% for carcinomas, 87% for STSs, and 76% for MCTs. CONCLUSIONS AND CLINICAL RELEVANCE: Histologic assessment of margin status was useful for predicting local recurrence of cutaneous malignant tumors in dogs and cats treated by means of excision alone. Method accuracy varied among tumor types and grades. Recurrence times suggested postsurgical follow-up should continue for ≥ 2 years. Results were similar for animals with infiltrated and close tumor margins, and careful postsurgical management is recommended for both.

Entities:  

Mesh:

Year:  2012        PMID: 22559107     DOI: 10.2460/javma.240.10.1181

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  10 in total

1.  Intra-operative imaging of surgical margins of canine soft tissue sarcoma using optical coherence tomography.

Authors:  Laura E Selmic; Jonathan Samuelson; Jennifer K Reagan; Kelly J Mesa; Elizabeth Driskell; Joanne Li; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2018-11-13       Impact factor: 2.613

2.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

3.  A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.

Authors:  Suzanne Bartholf DeWitt; William C Eward; Cindy A Eward; Alexander L Lazarides; Melodi Javid Whitley; Jorge M Ferrer; Brian E Brigman; David G Kirsch; John Berg
Journal:  Vet Surg       Date:  2016-06-09       Impact factor: 1.495

4.  Evaluation of the effect of formalin fixation on skin specimens in dogs and cats.

Authors:  Jaimie L Miller; Michael J Dark
Journal:  PeerJ       Date:  2014-03-13       Impact factor: 2.984

5.  Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).

Authors:  Galina V Ilyinskaya; Elena V Mukhina; Alesya V Soboleva; Olga V Matveeva; Peter M Chumakov
Journal:  Front Vet Sci       Date:  2018-06-04

6.  Evaluation of information presented within mast cell tumour histopathology reports in the United States: 2012-2015.

Authors:  Jennifer K Reagan; Laura E Selmic; Caroline Fallon; Elizabeth A Driskell; Laura D Garrett
Journal:  Vet Med Sci       Date:  2018-06-07

Review 7.  Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.

Authors:  Andrigo Barboza de Nardi; Rodrigo Dos Santos Horta; Carlos Eduardo Fonseca-Alves; Felipe Noleto de Paiva; Laís Calazans Menescal Linhares; Bruna Fernanda Firmo; Felipe Augusto Ruiz Sueiro; Krishna Duro de Oliveira; Silvia Vanessa Lourenço; Ricardo De Francisco Strefezzi; Carlos Henrique Maciel Brunner; Marcelo Monte Mor Rangel; Paulo Cesar Jark; Jorge Luiz Costa Castro; Rodrigo Ubukata; Karen Batschinski; Renata Afonso Sobral; Natália Oyafuso da Cruz; Adriana Tomoko Nishiya; Simone Crestoni Fernandes; Simone Carvalho Dos Santos Cunha; Daniel Guimarães Gerardi; Guilherme Sellera Godoy Challoub; Luiz Roberto Biondi; Renee Laufer-Amorim; Paulo Ricardo de Oliveira Paes; Gleidice Eunice Lavalle; Rafael Ricardo Huppes; Fabrizio Grandi; Carmen Helena de Carvalho Vasconcellos; Denner Santos Dos Anjos; Ângela Cristina Malheiros Luzo; Julia Maria Matera; Miluse Vozdova; Maria Lucia Zaidan Dagli
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

8.  Evaluating optical coherence tomography for surgical margin assessment of canine mammary tumours.

Authors:  Carolina Fabelo; Laura E Selmic; Pin-Cheh Huang; Jonathan P Samuelson; Jennifer K Reagan; Alexandra Kalamaras; Vincent Wavreille; Guillermo L Monroy; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2020-07-26       Impact factor: 2.613

9.  MRI-Based Assessment of Safe Margins in Tumor Surgery.

Authors:  Laura Bellanova; Thomas Schubert; Olivier Cartiaux; Frédéric Lecouvet; Christine Galant; Xavier Banse; Pierre-Louis Docquier
Journal:  Sarcoma       Date:  2014-02-20

10.  Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate.

Authors:  Pamela D Jones; Justine E Campbell; Graham Brown; Chad M Johannes; Paul Reddell
Journal:  J Vet Intern Med       Date:  2020-12-22       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.